Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20163
20182
20193
20202
20212
20224
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting7
Terminated6
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Alterome Therapeutics, Inc.1
Astellas Pharma Global Development, Inc.1
BerGenBio ASA1
Boryung Pharmaceutical Co., Ltd1
Daewoong Pharmaceutical Co. LTD.1
Five Prime Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms26
Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Neoplasms8
Stomach Neoplasms8
Colorectal Neoplasms7
Endometrial Neoplasms7
Squamous Cell Carcinoma of Head and Neck7
Esophageal Neoplasms6
Pancreatic Neoplasms6

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.